1. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial 
Jerrold H. Levy, MD, Lawrence T. Goodnough, MD, Philip E. Greilich, MD, Grant V.S. Parr, MD, Robert W. Stewart, MD, Irwin Gratz, DO, Joyce Wahr, MD, John Williams, MD, Mark E. Comunale, MD, Dennis Doblar, PhD, MD, George Silvay, MD, Marc Cohen, MD, Jonathan S. Jahr, MD, Gus J. Vlahakes, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 124, Issue 1, Pages (July 2002)
DOI: /mtc
Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

2. Fig. 1
Study protocol. Study-related procedures and monitoring, from screening through follow-up, are depicted.
The Journal of Thoracic and Cardiovascular Surgery  , 35-42DOI: ( /mtc )
Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

3. Fig. 2
Serial hematocrit (A) and hemoglobin (B) measurements for patients in HBOC and RBC groups.
The Journal of Thoracic and Cardiovascular Surgery  , 35-42DOI: ( /mtc )
Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

4. Fig. 3
Proportions of patients remaining hospitalized in terms of days after cardiac surgery for HBOC and RBC groups. Hospital stays were similar (P =.29).
The Journal of Thoracic and Cardiovascular Surgery  , 35-42DOI: ( /mtc )
Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions